文献速递消化与肝胆胰病理细胞病理与分子病理

胰腺伴破骨细胞样巨细胞的未分化癌:15例细胞学特征与临床意义

Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases.
PubMed 文献 · Cancer Cytopathol · 2017-04-03

分析15例胰腺伴破骨细胞样巨细胞的未分化癌(UOC)细针穿刺(FNA)标本的细胞学与临床病理特征。3种经典细胞类型在80%标本中可见,常合并胰腺导管腺癌(PDAC);FNA诊断UOC者中位总生存8个月,与PDAC相似但差于未行FNA的UOC患者。

要点

  • UOC的3种经典细胞类型可在FNA中识别,需纳入鉴别诊断。
  • UOC常合并PDAC成分,FNA标本中亦常见。
  • FNA诊断UOC者生存与PDAC相似,但差于未行FNA的UOC。

核心结论

  • UOC的3种经典细胞类型可在FNA中识别,使细胞学诊断成为可能。
  • UOC常合并PDAC成分。
  • FNA诊断UOC者的生存优势相较于纯PDAC似乎被抵消,需进一步研究。

研究设计与样本

  • 回顾性分析15例UOC的FNA标本的细胞学与临床病理特征。
  • FNA标本来自6名男性和8名女性,平均年龄65岁。
  • 肿瘤位于胰头7例、胰体3例、胰尾4例,平均影像学大小7.3 cm,9例有囊性成分。

主要发现

  • 12/15(80%)标本中可见3种细胞类型:破骨细胞样巨细胞、多形性肿瘤巨细胞和梭形/组织细胞样细胞。
  • 11例标本中存在PDAC成分。
  • FNA诊断:UOC 6例、PDAC 5例、低分化癌2例、可疑肿瘤1例、阴性1例。
  • 5/5例破骨细胞样巨细胞CD68阳性;多形性肿瘤巨细胞和梭形/组织细胞样细胞pancytokeratin阳性6/7、CAM5.2阳性2/3、EMA阳性2/2;INI-1保留3/3。
  • Ki-67增殖指数在3例中分别为12%、18%和40%;12例切除UOC中4例为纯UOC、8例混合PDAC;1例切除标本伴IPMN、2例伴MCN。

关键数值与推荐

  • FNA诊断UOC者中位总生存8个月(6例死亡,OS 8个月,范围2-22个月;8例存活,OS 3个月,范围1-27个月)。
  • FNA诊断UOC者与FNA诊断PDAC的74例患者生存相似(OS 15个月,P = .279)。
  • FNA诊断UOC者生存差于未行FNA的27例UOC患者(OS 92个月,P = .0135)。

临床怎么用

  • 当FNA标本中出现破骨细胞样巨细胞、多形性肿瘤巨细胞和梭形/组织细胞样细胞时,应将UOC纳入鉴别诊断。
  • 注意识别合并的PDAC成分,因其常见。
  • FNA诊断UOC者的生存预后可能与PDAC相似,需结合临床综合评估。

局限性

  • 回顾性分析,样本量小(15例FNA标本)。
  • 部分检测(如Ki-67)仅在少数标本中评估。
  • FNA对UOC生存优势的影响需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The cytologic features of undifferentiated pancreatic carcinoma with osteoclastic giant cells (UOC) are rarely described. METHODS: Cytologic and clinicopathologic characteristics in 15 UOC fine-needle aspiration (FNA) specimens were analyzed. RESULTS: FNA specimens were obtained from 6 men and 8 women with a mean age of 65 years who had UOCs (head, n = 7; body, n = 3; and tail, n = 4) with a mean radiologic size 7.3 cm, and some had a cystic component (n = 9). Three cell types (osteoclastic giant cells, pleomorphic tumor giant cells, and spindled/histiocytoid cells) were observed in 12 of 15 specimens (80%); and pancreatic ductal adenocarcinoma (PDAC) was present in 11 specimens. FNA diagnoses were UOC (n = 6), PDAC (n = 5), poorly differentiated carcinoma (n = 2), "suspicious for neoplasm" (n = 1), and "negative" (n = 1). Five of 5 specimens with osteoclastic giant cells were positive for cluster of differentiation 68 (CD68) (a glycoprotein that binds to low-density lipoprotein). Pleomorphic tumor giant cells and spindled/histiocytoid cells were positive for pancytokeratin (6 of 7 specimens), CAM5.2 (2 of 3 specimens), and epithelial membrane antigen (2 of 2 specimens). INI-1 protein expression was retained in 3 of 3 specimens. The Ki-67 labeling index was assessed in 3 specimens and was 12%, 18%, and 40%; 4 of 12 resected UOCs were pure, and 8 were mixed with PDAC. One resection specimen had intraductal papillary mucinous neoplasm, and 2 had mucinous cystic neoplasms. The median overall survival (OS) of patients who had UOCs identified on FNA was 8 months (6 died [OS, 8 months; range, 2-22 months], and 8 remained alive [OS, 3 months; range, 1-27 months]), which was similar to the survival of 74 patients who had PDACs identified on FNA (OS, 15 months; P = .279) but worse than that of the 27 patients with UOCs who did not undergo FNA (OS, 92 months; P = .0135). CONCLUSIONS: The 3 classical UOC cell types are identifiable on FNA, making cytologic diagnosis possible if considered in the differential. A PDAC component is often also observed. The survival advantage of UOC over pure PDAC appears to be negated by FNA and requires further investigation. Cancer Cytopathol 2017;125:563-75. © 2017 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Reid MD, Muraki T, HooKim K, et al. Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases. Cancer Cytopathol. 2017. PMID: 28371566. doi:10.1002/cncy.21859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。